StockData
Vycor Medical Inc logo

Vycor Medical Inc (VYCO) stock

VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.07+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.24MP/E –Yield –

Vycor Medical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Vycor Medical's free cash flow for the twelve months ending Dec 31, 2025 was -$18.70K, down 134.1% year over year. For fiscal 2025 it was -$18.70K, down 134.1% from the year before. The highest annual figure on record is $54.74K in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$18.70K-134.1%
FY2024Dec 31, 2024$54.74K+173.1%
FY2023Dec 31, 2023$20.04K–
FY2022Dec 31, 2022-$219.80K–
FY2021Dec 31, 2021-$17.01K–
FY2020Dec 31, 2020-$310.84K–
FY2019Dec 31, 2019-$58.92K–
FY2018Dec 31, 2018-$323.85K–
FY2017Dec 31, 2017-$710.70K–
FY2016Dec 31, 2016-$554.37K–
FY2015Dec 31, 2015-$1.38M–
FY2014Dec 31, 2014-$2.83M–
FY2013Dec 31, 2013-$886.48K–
FY2012Dec 31, 2012-$1.40M–
FY2011Dec 31, 2011-$3.26M–
FY2010Dec 31, 2010-$1.47M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$37.63K–
Q3 FY2025Sep 30, 2025-$72.43K–
Q4 FY2024Dec 31, 2024-$38.28K-220.5%
Q4 FY2023Dec 31, 2023-$396–
Q4 FY2022Dec 31, 2022-$33.03K-142.3%
Q3 FY2022Sep 30, 2022-$76.65K–
Q4 FY2021Dec 31, 2021$31.77K–
Q3 FY2021Sep 30, 2021-$68.84K–
Q2 FY2021Jun 30, 2021$78.16K–
Q1 FY2021Mar 31, 2021-$58.10K–
Q4 FY2020Dec 31, 2020-$7.85K–
Q3 FY2020Sep 30, 2020-$173.87K-4833.8%
Q2 FY2020Jun 30, 2020-$47.89K–
Q1 FY2020Mar 31, 2020-$81.23K–
Q4 FY2019Dec 31, 2019-$26.57K-240.6%
Q3 FY2019Sep 30, 2019$3.67K–
Q2 FY2019Jun 30, 2019-$11.65K–
Q1 FY2019Mar 31, 2019-$24.38K–
Q4 FY2018Dec 31, 2018$18.89K–
Q3 FY2018Sep 30, 2018-$42.59K–
Q2 FY2018Jun 30, 2018-$142.25K–
Q1 FY2018Mar 31, 2018-$157.90K–
Q4 FY2017Dec 31, 2017-$199.16K–
Q3 FY2017Sep 30, 2017-$174.01K–
Q2 FY2017Jun 30, 2017-$23.40K–
Q1 FY2017Mar 31, 2017-$314.13K–
Q4 FY2016Dec 31, 2016-$140.43K–
Q3 FY2016Sep 30, 2016-$10.83K–

More Vycor Medical figures

See a number that looks wrong?